Please provide your email address to receive an email when new articles are posted on . A single 1,000-mg infusion of rituximab significantly slows the development of arthritis among patients at risk ...
First Anti-TNF Infusion Therapy Approved in More Than a Decade for Patients Living with Moderately to Severely Active Rheumatoid Arthritis "Phase 3 data showed treatment with SIMPONI ARIA plus ...
Rituxan (rituximab) is a prescription drug used to treat certain cancers, rheumatoid arthritis (RA), and other conditions. Rituxan comes as an intravenous (IV) infusion. Rituxan is a type of ...
Your doctor has recommended expanding your treatment plan for rheumatoid arthritis (RA) to include an interleukin 6 (IL-6) inhibitor — a biologic that’s often prescribed when conventional ...
THOUSAND OAKS, Calif., June 6, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNI™ (rituximab-arrx), a biosimilar to Rituxan® ...
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that STAGE, a Phase III trial evaluating ocrelizumab as a treatment for seropositive* rheumatoid arthritis (RA) patients with a previous inadequate ...
When you have rheumatoid arthritis (RA) and take a biologic, the best source of daily-life advice, coping tips, and comfort may be people who are in the same boat. People with RA say they like to ...
A proof-of-concept trial has shown that zoledronic acid is effective in preventing bone erosions in patients with early rheumatoid arthritis (RA). Zoledronic acid is a third-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback